دورية أكاديمية

Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study

التفاصيل البيبلوغرافية
العنوان: Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study
المؤلفون: Eraksoy, Mefkure, Akman, Gülşen Demir, Agan, Kadriye, Günal, Dilek İnce, Us, Önder, Şaip, Sebahattin, Demirci, Nuri Onat, Tütüncü, Melih, Boz, Cavit, Terzi, Matthew C., Onar, Musa, Aydin, H. Güngör, Türk, U. Boru, Soysal, Aysun, Petek, Belgin Balcı, Türkoğlu, Recai, Dib, Hussein, Siva, Aksel
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı., Turan, Ömer Faruk, Taşkapılıoğlu, Özlem
بيانات النشر: Elsevier
سنة النشر: 2009
المجموعة: Açık Erişim@BUU (Bursa Uludağ Üniversitesi)
مصطلحات موضوعية: Neurosciences & neurology, Clinical neurology, Neurosciences
الوصف: Bu çalışma, 24-30 Ekim 2009 tarihleri arasında Bangkok[Tayland]’da düzenlenen 19. World Congress of Neurology’da bildiri olarak sunulmuştur.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0022-510X
العلاقة: Konferans Öğesi - Uluslararası; Journal of the Neurological Sciences; Yurt içi; Sanayi; Eraksoy, M. vd. (2009). "Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study". Journal of the Neurological Sciences, 285(Supplement 1), S209-S209.; https://doi.org/10.1016/S0022-510XTest(09)70798-1; https://www.sciencedirect.com/science/article/pii/S0022510X09707981Test; http://hdl.handle.net/11452/26979Test; 000272521300731; S209; 285; Supplement 1
DOI: 10.1016/S0022-510X(09)70798-1
الإتاحة: https://doi.org/10.1016/S0022-510XTest(09)70798-1
http://hdl.handle.net/11452/26979Test
https://www.sciencedirect.com/science/article/pii/S0022510X09707981Test
حقوق: info:eu-repo/semantics/closedAccess
رقم الانضمام: edsbas.E5E1FB80
قاعدة البيانات: BASE
الوصف
تدمد:0022510X
DOI:10.1016/S0022-510X(09)70798-1